We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.32%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$502M
AUM Growth
+$38.7M
Cap. Flow
+$35.5M
Cap. Flow %
7.08%
Top 10 Hldgs %
35.28%
Holding
145
New
16
Increased
39
Reduced
29
Closed

Top Buys

Rank Stock Value
1
UNM icon
Unum
UNM
+$13.4M
2
ENOV icon
Enovis
ENOV
+$12.6M
3
AFL icon
Aflac
AFL
+$3.92M
4
QCOM icon
Qualcomm
QCOM
+$2.08M
5
MMM icon
3M
MMM
+$1.59M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$7.31M
2
SWN
Southwestern Energy Company
SWN
+$3.07M
3
AAPL icon
Apple
AAPL
+$1.29M
4
ELV icon
Elevance Health
ELV
+$913K
5
CSCO icon
Cisco
CSCO
+$810K

Sector Composition

Rank Sector Weight
1 Healthcare 22.41%
2 Technology 17.31%
3 Financials 15%
4 Consumer Discretionary 10.99%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
51
Amgen
AMGN
$226B
$777K 0.15%
5,062
+4,900
+3,025% +$785K
PFE icon
52
Pfizer
PFE
$154B
$739K 0.15%
23,222
-1,091
-4% -$35.6K
SI
53
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$738K 0.15%
7,330
ABBV icon
54
AbbVie
ABBV
$438B
$666K 0.13%
9,910
AGN
55
DELISTED
Allergan plc
AGN
$660K 0.13%
2,174
-846
-28% -$252K
EW icon
56
Edwards Lifesciences
EW
$53B
$655K 0.13%
27,600
ALB icon
57
Albemarle
ALB
$15.5B
$643K 0.13%
11,640
VOD icon
58
Vodafone
VOD
$36.4B
$608K 0.12%
16,682
APD icon
59
Air Products & Chemicals
APD
$68.6B
$602K 0.12%
+4,756
New +$649K
SCHW
60
Charles Schwab
SCHW
$188B
$586K 0.12%
17,957
SNN icon
61
Smith & Nephew
SNN
$12.6B
$570K 0.11%
16,800
+800
+5% +$27.8K
MSFT icon
62
Microsoft
MSFT
$3.76T
$512K 0.1%
11,613
-50
-0.4% -$2.28K
ABT icon
63
Abbott
ABT
$188B
$479K 0.1%
9,760
-200
-2% -$9.6K
BMY icon
64
Bristol-Myers Squibb
BMY
$132B
$448K 0.09%
6,742
-25
-0.4% -$1.65K
RTX icon
65
RTX Corp
RTX
$302B
$438K 0.09%
6,281
+1,355
+28% +$99.4K
SNY icon
66
Sanofi
SNY
$104B
$393K 0.08%
7,925
+3,050
+63% +$155K
PCAR icon
67
PACCAR
PCAR
$69.1B
$391K 0.08%
9,188
AVY icon
68
Avery Dennison
AVY
$13.5B
$384K 0.08%
6,300
+650
+12% +$37.8K
MET icon
69
MetLife
MET
$61.7B
$384K 0.08%
7,687
VRSN icon
70
VeriSign
VRSN
$26.5B
$380K 0.08%
6,153
BP icon
71
BP
BP
$110B
$366K 0.07%
10,874
-153
-1% -$5.36K
TEVA icon
72
Teva Pharmaceuticals
TEVA
$42.1B
$361K 0.07%
6,100
SYT
73
DELISTED
Syngenta Ag
SYT
$359K 0.07%
+4,400
New +$354K
ORCL icon
74
Oracle
ORCL
$435B
$354K 0.07%
8,800
SWH
75
DELISTED
Stanley Black & Decker, Inc.
SWH
$343K 0.07%
2,900
+2,200
+314% +$258K

Similar funds

Kelly Lawrence W & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Kelly Lawrence W & Associates held 145 positions worth $502M, up 8.3% from $463M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kelly Lawrence W & Associates deployed $35.5M of net new capital in Q2 2015, opening 16 new positions and adding to 39 existing holdings. Its largest new stake was Enovis: 148,437 shares worth $11.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Viatris, an estimated $7.31M trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2015 buy was Enovis: 148,437 shares worth $11.8M.
  • Kelly Lawrence W & Associates added most to Unum in Q2 2015, an estimated $13.4M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2015 reduction was Viatris, cutting an estimated $7.31M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 35% of its $502M portfolio in Q2 2015.
  • Kelly Lawrence W & Associates opened 16 new positions and closed 0 in Q2 2015.
  • Kelly Lawrence W & Associates's portfolio value rose 8.3% quarter-over-quarter to $502M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.